About 757,000 results
Open links in new tab
  1. Immune thrombocytopenia (ITP) - Symptoms and causes

    Apr 29, 2025 · Immune thrombocytopenia (ITP) is an illness that can lead to bruising and bleeding. Low levels of the cells that help blood clot, also known as platelets, most often cause …

  2. Idiopathic Thrombocytopenic Purpura - Johns Hopkins Medicine

    Immune thrombocytopenic purpura (ITP) is a blood disorder. With this disease, you have a lower amount of platelets than normal in your blood. Platelets are blood cell fragments that help with …

  3. Immune Thrombocytopenia (ITP): Symptoms, Diagnosis

    Immune thrombocytopenia (ITP) is a bleeding disorder that keeps your blood from clotting. ITP can be chronic, meaning treatment eases symptoms but doesn’t cure it.

  4. Platelet Disorders - Immune Thrombocytopenia (ITP) | NHLBI, NIH

    Jul 24, 2025 · Immune thrombocytopenia (ITP) is caused by your immune system attacking your platelets. It can cause serious bleeding. Learn about ITP symptoms and treatments.

  5. Immune thrombocytopenic purpura - Wikipedia

    Acute ITP often follows a viral infection and is typically self-limited (resolving within two months), while the more chronic form (persisting for longer than six months) does not yet have a …

  6. Immune thrombocytopenic purpura (ITP) - Harvard Health

    Jun 6, 2025 · In short, ITP is an illness in which unusually low levels of platelets lead to purpura and other forms of abnormal bleeding. In people with ITP, the immune system produces …

  7. Immune Thrombocytopenia (ITP) - Hematology and Oncology

    Immune thrombocytopenia (ITP) is a bleeding disorder usually without anemia or leukopenia. Typically, it is chronic in adults, but it is usually acute and self-limited in children.

  8. Health Encyclopedia - University of Rochester Medical Center

    Immune thrombocytopenic purpura (ITP) is a blood disorder. With this disease, you have a lower amount of platelets than normal in your blood. Platelets are blood cell fragments that help with …

  9. Rilzabrutinib Offers a New, Well-Tolerated Option for Patients With ITP

    6 days ago · Rilzabrutinib (Wayrilz; Sanofi), a BTK inhibitor, targets immune-mediated platelet destruction in immune thrombocytopenia (ITP) and has demonstrated a favorable safety profile.

  10. Chronic Immune Thrombocytopenia (ITP) - WebMD

    Dec 8, 2025 · Immune thrombocytopenia (ITP) is a rare blood disorder. Your immune system mistakenly destroys platelets, cell fragments that help your blood clot after an injury. The lack …